nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP2C18—malignant glioma	0.396	0.574	CbGaD
Propofol—CYP2B6—malignant glioma	0.294	0.426	CbGaD
Propofol—CYP1A2—Carmustine—malignant glioma	0.0495	0.569	CbGbCtD
Propofol—CYP3A4—Temozolomide—malignant glioma	0.0374	0.43	CbGbCtD
Propofol—FAAH—telencephalic ventricle—malignant glioma	0.00713	0.142	CbGeAlD
Propofol—Intracranial pressure increased—Carmustine—malignant glioma	0.00235	0.044	CcSEcCtD
Propofol—FAAH—brainstem—malignant glioma	0.00193	0.0383	CbGeAlD
Propofol—FAAH—telencephalon—malignant glioma	0.00171	0.034	CbGeAlD
Propofol—Thrombosis—Carmustine—malignant glioma	0.00138	0.026	CcSEcCtD
Propofol—FAAH—medulla oblongata—malignant glioma	0.00135	0.0267	CbGeAlD
Propofol—FAAH—midbrain—malignant glioma	0.00123	0.0244	CbGeAlD
Propofol—Coagulopathy—Temozolomide—malignant glioma	0.00122	0.0228	CcSEcCtD
Propofol—Injection site pain—Carmustine—malignant glioma	0.0012	0.0225	CcSEcCtD
Propofol—FAAH—spinal cord—malignant glioma	0.0012	0.0238	CbGeAlD
Propofol—Extravasation—Carmustine—malignant glioma	0.00112	0.0211	CcSEcCtD
Propofol—SCN2A—brainstem—malignant glioma	0.00111	0.022	CbGeAlD
Propofol—Thinking abnormal—Carmustine—malignant glioma	0.00107	0.0201	CcSEcCtD
Propofol—Leukocytosis—Carmustine—malignant glioma	0.00104	0.0196	CcSEcCtD
Propofol—SCN2A—telencephalon—malignant glioma	0.000984	0.0195	CbGeAlD
Propofol—FAAH—central nervous system—malignant glioma	0.000973	0.0193	CbGeAlD
Propofol—Respiratory failure—Temozolomide—malignant glioma	0.000964	0.0181	CcSEcCtD
Propofol—FAAH—cerebellum—malignant glioma	0.000951	0.0189	CbGeAlD
Propofol—GABRB2—brainstem—malignant glioma	0.000942	0.0187	CbGeAlD
Propofol—Neuropathy—Carmustine—malignant glioma	0.00092	0.0173	CcSEcCtD
Propofol—Neuropathy—Temozolomide—malignant glioma	0.000889	0.0167	CcSEcCtD
Propofol—GABRA2—brainstem—malignant glioma	0.000861	0.0171	CbGeAlD
Propofol—Abnormal vision—Carmustine—malignant glioma	0.000855	0.016	CcSEcCtD
Propofol—Sepsis—Carmustine—malignant glioma	0.00085	0.0159	CcSEcCtD
Propofol—Mental disability—Carmustine—malignant glioma	0.00085	0.0159	CcSEcCtD
Propofol—GABRB2—telencephalon—malignant glioma	0.000836	0.0166	CbGeAlD
Propofol—GABRG2—telencephalon—malignant glioma	0.000836	0.0166	CbGeAlD
Propofol—GABRA1—brainstem—malignant glioma	0.000832	0.0165	CbGeAlD
Propofol—Abnormal vision—Temozolomide—malignant glioma	0.000826	0.0155	CcSEcCtD
Propofol—Phlebitis—Carmustine—malignant glioma	0.000826	0.0155	CcSEcCtD
Propofol—Mental disability—Temozolomide—malignant glioma	0.000822	0.0154	CcSEcCtD
Propofol—Ear pain—Temozolomide—malignant glioma	0.000806	0.0151	CcSEcCtD
Propofol—Eye pain—Carmustine—malignant glioma	0.000788	0.0148	CcSEcCtD
Propofol—SCN2A—medulla oblongata—malignant glioma	0.000774	0.0154	CbGeAlD
Propofol—FAAH—brain—malignant glioma	0.000773	0.0153	CbGeAlD
Propofol—GABRA2—telencephalon—malignant glioma	0.000764	0.0152	CbGeAlD
Propofol—Eye pain—Temozolomide—malignant glioma	0.000761	0.0143	CcSEcCtD
Propofol—GABRA1—telencephalon—malignant glioma	0.000738	0.0147	CbGeAlD
Propofol—Diplopia—Carmustine—malignant glioma	0.000711	0.0133	CcSEcCtD
Propofol—SCN2A—midbrain—malignant glioma	0.000707	0.014	CbGeAlD
Propofol—SCN2A—spinal cord—malignant glioma	0.00069	0.0137	CbGeAlD
Propofol—Diplopia—Temozolomide—malignant glioma	0.000687	0.0129	CcSEcCtD
Propofol—Affect lability—Temozolomide—malignant glioma	0.000677	0.0127	CcSEcCtD
Propofol—GABRB2—medulla oblongata—malignant glioma	0.000657	0.013	CbGeAlD
Propofol—GABRG2—medulla oblongata—malignant glioma	0.000657	0.013	CbGeAlD
Propofol—Mood swings—Temozolomide—malignant glioma	0.000651	0.0122	CcSEcCtD
Propofol—GABRB3—telencephalon—malignant glioma	0.000642	0.0128	CbGeAlD
Propofol—Dehydration—Temozolomide—malignant glioma	0.000639	0.012	CcSEcCtD
Propofol—CYP1B1—telencephalon—malignant glioma	0.000634	0.0126	CbGeAlD
Propofol—SCN4A—central nervous system—malignant glioma	0.000632	0.0126	CbGeAlD
Propofol—GABRB2—midbrain—malignant glioma	0.000601	0.0119	CbGeAlD
Propofol—GABRG2—midbrain—malignant glioma	0.000601	0.0119	CbGeAlD
Propofol—GABRB2—spinal cord—malignant glioma	0.000586	0.0116	CbGeAlD
Propofol—GABRG2—spinal cord—malignant glioma	0.000586	0.0116	CbGeAlD
Propofol—GABRA1—medulla oblongata—malignant glioma	0.00058	0.0115	CbGeAlD
Propofol—Sweating increased—Temozolomide—malignant glioma	0.000579	0.0109	CcSEcCtD
Propofol—SCN2A—central nervous system—malignant glioma	0.00056	0.0111	CbGeAlD
Propofol—Hyperglycaemia—Carmustine—malignant glioma	0.000555	0.0104	CcSEcCtD
Propofol—SCN2A—cerebellum—malignant glioma	0.000547	0.0109	CbGeAlD
Propofol—Depression—Carmustine—malignant glioma	0.000547	0.0103	CcSEcCtD
Propofol—Renal failure—Carmustine—malignant glioma	0.000539	0.0101	CcSEcCtD
Propofol—Neuropathy peripheral—Carmustine—malignant glioma	0.000537	0.0101	CcSEcCtD
Propofol—Hyperglycaemia—Temozolomide—malignant glioma	0.000536	0.0101	CcSEcCtD
Propofol—GABRA1—midbrain—malignant glioma	0.00053	0.0105	CbGeAlD
Propofol—Depression—Temozolomide—malignant glioma	0.000528	0.00991	CcSEcCtD
Propofol—Neuropathy peripheral—Temozolomide—malignant glioma	0.000519	0.00974	CcSEcCtD
Propofol—GABRA1—spinal cord—malignant glioma	0.000517	0.0103	CbGeAlD
Propofol—GABRB3—medulla oblongata—malignant glioma	0.000505	0.01	CbGeAlD
Propofol—SCN4A—brain—malignant glioma	0.000502	0.00997	CbGeAlD
Propofol—Haemoglobin—Carmustine—malignant glioma	0.000495	0.00928	CcSEcCtD
Propofol—Haemorrhage—Carmustine—malignant glioma	0.000492	0.00923	CcSEcCtD
Propofol—Hallucination—Carmustine—malignant glioma	0.00049	0.00918	CcSEcCtD
Propofol—CYP2A6—cerebellum—malignant glioma	0.00048	0.00954	CbGeAlD
Propofol—Haemoglobin—Temozolomide—malignant glioma	0.000478	0.00896	CcSEcCtD
Propofol—Haemorrhage—Temozolomide—malignant glioma	0.000475	0.00892	CcSEcCtD
Propofol—GABRB2—central nervous system—malignant glioma	0.000475	0.00944	CbGeAlD
Propofol—GABRG2—central nervous system—malignant glioma	0.000475	0.00944	CbGeAlD
Propofol—Visual impairment—Carmustine—malignant glioma	0.000474	0.00889	CcSEcCtD
Propofol—Hallucination—Temozolomide—malignant glioma	0.000473	0.00887	CcSEcCtD
Propofol—Pharyngitis—Temozolomide—malignant glioma	0.000472	0.00885	CcSEcCtD
Propofol—GABRB2—cerebellum—malignant glioma	0.000465	0.00922	CbGeAlD
Propofol—GABRG2—cerebellum—malignant glioma	0.000465	0.00922	CbGeAlD
Propofol—GABRB3—midbrain—malignant glioma	0.000461	0.00916	CbGeAlD
Propofol—Visual impairment—Temozolomide—malignant glioma	0.000458	0.0086	CcSEcCtD
Propofol—Flushing—Carmustine—malignant glioma	0.000457	0.00857	CcSEcCtD
Propofol—GABRB3—spinal cord—malignant glioma	0.00045	0.00893	CbGeAlD
Propofol—SCN2A—brain—malignant glioma	0.000444	0.00882	CbGeAlD
Propofol—Tinnitus—Temozolomide—malignant glioma	0.000443	0.00832	CcSEcCtD
Propofol—Flushing—Temozolomide—malignant glioma	0.000441	0.00828	CcSEcCtD
Propofol—Arrhythmia—Carmustine—malignant glioma	0.00044	0.00825	CcSEcCtD
Propofol—GABRA2—central nervous system—malignant glioma	0.000434	0.00862	CbGeAlD
Propofol—Erythema—Carmustine—malignant glioma	0.000428	0.00803	CcSEcCtD
Propofol—Chills—Temozolomide—malignant glioma	0.000427	0.008	CcSEcCtD
Propofol—GABRA2—cerebellum—malignant glioma	0.000424	0.00843	CbGeAlD
Propofol—GABRA1—central nervous system—malignant glioma	0.00042	0.00833	CbGeAlD
Propofol—Erythema—Temozolomide—malignant glioma	0.000414	0.00776	CcSEcCtD
Propofol—GABRA1—cerebellum—malignant glioma	0.00041	0.00815	CbGeAlD
Propofol—CYP2E1—telencephalon—malignant glioma	0.000409	0.00811	CbGeAlD
Propofol—Dysgeusia—Temozolomide—malignant glioma	0.000405	0.0076	CcSEcCtD
Propofol—Tremor—Carmustine—malignant glioma	0.000401	0.00753	CcSEcCtD
Propofol—Agitation—Carmustine—malignant glioma	0.000394	0.00738	CcSEcCtD
Propofol—CYP2A6—brain—malignant glioma	0.00039	0.00775	CbGeAlD
Propofol—Tremor—Temozolomide—malignant glioma	0.000388	0.00727	CcSEcCtD
Propofol—Agitation—Temozolomide—malignant glioma	0.00038	0.00714	CcSEcCtD
Propofol—Angioedema—Temozolomide—malignant glioma	0.000378	0.00709	CcSEcCtD
Propofol—GABRB2—brain—malignant glioma	0.000377	0.00749	CbGeAlD
Propofol—GABRG2—brain—malignant glioma	0.000377	0.00749	CbGeAlD
Propofol—Convulsion—Carmustine—malignant glioma	0.000371	0.00696	CcSEcCtD
Propofol—Hypertension—Carmustine—malignant glioma	0.00037	0.00694	CcSEcCtD
Propofol—GABRB3—central nervous system—malignant glioma	0.000365	0.00725	CbGeAlD
Propofol—Myalgia—Carmustine—malignant glioma	0.000365	0.00684	CcSEcCtD
Propofol—Chest pain—Carmustine—malignant glioma	0.000365	0.00684	CcSEcCtD
Propofol—CYP2D6—brainstem—malignant glioma	0.000365	0.00724	CbGeAlD
Propofol—Anxiety—Carmustine—malignant glioma	0.000363	0.00682	CcSEcCtD
Propofol—Cough—Temozolomide—malignant glioma	0.000361	0.00678	CcSEcCtD
Propofol—CYP1B1—central nervous system—malignant glioma	0.00036	0.00715	CbGeAlD
Propofol—Convulsion—Temozolomide—malignant glioma	0.000359	0.00673	CcSEcCtD
Propofol—Hypertension—Temozolomide—malignant glioma	0.000357	0.0067	CcSEcCtD
Propofol—GABRB3—cerebellum—malignant glioma	0.000357	0.00708	CbGeAlD
Propofol—Confusional state—Carmustine—malignant glioma	0.000352	0.00661	CcSEcCtD
Propofol—Myalgia—Temozolomide—malignant glioma	0.000352	0.00661	CcSEcCtD
Propofol—CYP1B1—cerebellum—malignant glioma	0.000352	0.00699	CbGeAlD
Propofol—Anxiety—Temozolomide—malignant glioma	0.000351	0.00659	CcSEcCtD
Propofol—Oedema—Carmustine—malignant glioma	0.00035	0.00656	CcSEcCtD
Propofol—GABRA2—brain—malignant glioma	0.000345	0.00685	CbGeAlD
Propofol—Dry mouth—Temozolomide—malignant glioma	0.000345	0.00646	CcSEcCtD
Propofol—Tachycardia—Carmustine—malignant glioma	0.000341	0.0064	CcSEcCtD
Propofol—Confusional state—Temozolomide—malignant glioma	0.000341	0.00639	CcSEcCtD
Propofol—Oedema—Temozolomide—malignant glioma	0.000338	0.00634	CcSEcCtD
Propofol—Anaphylactic shock—Temozolomide—malignant glioma	0.000338	0.00634	CcSEcCtD
Propofol—GABRA1—brain—malignant glioma	0.000333	0.00662	CbGeAlD
Propofol—Hypotension—Carmustine—malignant glioma	0.000327	0.00613	CcSEcCtD
Propofol—Hyperhidrosis—Temozolomide—malignant glioma	0.000327	0.00613	CcSEcCtD
Propofol—CYP2D6—telencephalon—malignant glioma	0.000323	0.00642	CbGeAlD
Propofol—CYP2E1—medulla oblongata—malignant glioma	0.000321	0.00637	CbGeAlD
Propofol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000318	0.00597	CcSEcCtD
Propofol—Insomnia—Carmustine—malignant glioma	0.000316	0.00593	CcSEcCtD
Propofol—Paraesthesia—Carmustine—malignant glioma	0.000314	0.00589	CcSEcCtD
Propofol—Dyspnoea—Carmustine—malignant glioma	0.000312	0.00585	CcSEcCtD
Propofol—ALB—brain—malignant glioma	0.000312	0.00619	CbGeAlD
Propofol—Somnolence—Carmustine—malignant glioma	0.000311	0.00583	CcSEcCtD
Propofol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000308	0.00577	CcSEcCtD
Propofol—Insomnia—Temozolomide—malignant glioma	0.000306	0.00573	CcSEcCtD
Propofol—Paraesthesia—Temozolomide—malignant glioma	0.000303	0.00569	CcSEcCtD
Propofol—Dyspnoea—Temozolomide—malignant glioma	0.000301	0.00565	CcSEcCtD
Propofol—Somnolence—Temozolomide—malignant glioma	0.0003	0.00563	CcSEcCtD
Propofol—Pain—Carmustine—malignant glioma	0.000299	0.00561	CcSEcCtD
Propofol—Fatigue—Temozolomide—malignant glioma	0.000291	0.00546	CcSEcCtD
Propofol—GABRB3—brain—malignant glioma	0.00029	0.00575	CbGeAlD
Propofol—Pain—Temozolomide—malignant glioma	0.000289	0.00542	CcSEcCtD
Propofol—Feeling abnormal—Carmustine—malignant glioma	0.000288	0.0054	CcSEcCtD
Propofol—CYP2E1—spinal cord—malignant glioma	0.000286	0.00568	CbGeAlD
Propofol—CYP1B1—brain—malignant glioma	0.000286	0.00568	CbGeAlD
Propofol—Feeling abnormal—Temozolomide—malignant glioma	0.000278	0.00522	CcSEcCtD
Propofol—Abdominal pain—Carmustine—malignant glioma	0.000276	0.00518	CcSEcCtD
Propofol—Body temperature increased—Carmustine—malignant glioma	0.000276	0.00518	CcSEcCtD
Propofol—Urticaria—Temozolomide—malignant glioma	0.000268	0.00503	CcSEcCtD
Propofol—Body temperature increased—Temozolomide—malignant glioma	0.000267	0.00501	CcSEcCtD
Propofol—Abdominal pain—Temozolomide—malignant glioma	0.000267	0.00501	CcSEcCtD
Propofol—CYP1A1—central nervous system—malignant glioma	0.000255	0.00506	CbGeAlD
Propofol—Asthenia—Carmustine—malignant glioma	0.000251	0.0047	CcSEcCtD
Propofol—CYP2B6—central nervous system—malignant glioma	0.000247	0.00491	CbGeAlD
Propofol—Asthenia—Temozolomide—malignant glioma	0.000242	0.00455	CcSEcCtD
Propofol—Diarrhoea—Carmustine—malignant glioma	0.000239	0.00449	CcSEcCtD
Propofol—Pruritus—Temozolomide—malignant glioma	0.000239	0.00448	CcSEcCtD
Propofol—CYP2E1—central nervous system—malignant glioma	0.000232	0.00461	CbGeAlD
Propofol—Dizziness—Carmustine—malignant glioma	0.000231	0.00434	CcSEcCtD
Propofol—Diarrhoea—Temozolomide—malignant glioma	0.000231	0.00434	CcSEcCtD
Propofol—CYP2E1—cerebellum—malignant glioma	0.000227	0.00451	CbGeAlD
Propofol—Dizziness—Temozolomide—malignant glioma	0.000223	0.00419	CcSEcCtD
Propofol—Vomiting—Carmustine—malignant glioma	0.000222	0.00417	CcSEcCtD
Propofol—Rash—Carmustine—malignant glioma	0.00022	0.00413	CcSEcCtD
Propofol—Dermatitis—Carmustine—malignant glioma	0.00022	0.00413	CcSEcCtD
Propofol—CYP2C8—brain—malignant glioma	0.000219	0.00435	CbGeAlD
Propofol—Headache—Carmustine—malignant glioma	0.000219	0.00411	CcSEcCtD
Propofol—Vomiting—Temozolomide—malignant glioma	0.000215	0.00403	CcSEcCtD
Propofol—Rash—Temozolomide—malignant glioma	0.000213	0.004	CcSEcCtD
Propofol—Dermatitis—Temozolomide—malignant glioma	0.000213	0.00399	CcSEcCtD
Propofol—Headache—Temozolomide—malignant glioma	0.000212	0.00397	CcSEcCtD
Propofol—Nausea—Carmustine—malignant glioma	0.000208	0.00389	CcSEcCtD
Propofol—CYP1A1—brain—malignant glioma	0.000202	0.00401	CbGeAlD
Propofol—Nausea—Temozolomide—malignant glioma	0.000201	0.00376	CcSEcCtD
Propofol—CYP2B6—brain—malignant glioma	0.000196	0.0039	CbGeAlD
Propofol—CYP3A4—central nervous system—malignant glioma	0.000187	0.00371	CbGeAlD
Propofol—CYP2E1—brain—malignant glioma	0.000184	0.00366	CbGeAlD
Propofol—CYP2D6—central nervous system—malignant glioma	0.000184	0.00365	CbGeAlD
Propofol—CYP2D6—cerebellum—malignant glioma	0.00018	0.00357	CbGeAlD
Propofol—CYP2D6—brain—malignant glioma	0.000146	0.0029	CbGeAlD
Propofol—CYP2A6—Metabolism—CAT—malignant glioma	8.84e-06	7.39e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CAV1—malignant glioma	8.83e-06	7.38e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CAV1—malignant glioma	8.83e-06	7.38e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—BCHE—malignant glioma	8.51e-06	7.11e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.49e-06	7.1e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.49e-06	7.09e-05	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PIK3CA—malignant glioma	8.47e-06	7.08e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.43e-06	7.05e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SLC5A5—malignant glioma	8.4e-06	7.02e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTGS1—malignant glioma	8.39e-06	7.01e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.36e-06	6.99e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—NCOR1—malignant glioma	8.35e-06	6.98e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTGS1—malignant glioma	8.34e-06	6.97e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.31e-06	6.95e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CAV1—malignant glioma	8.23e-06	6.88e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.19e-06	6.85e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—RAF1—malignant glioma	8.15e-06	6.81e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—IDH1—malignant glioma	8.12e-06	6.79e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CG—malignant glioma	8.04e-06	6.72e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CG—malignant glioma	8.04e-06	6.72e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTT1—malignant glioma	7.99e-06	6.68e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CB—malignant glioma	7.96e-06	6.65e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.95e-06	6.64e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.87e-06	6.58e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.86e-06	6.57e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SPHK1—malignant glioma	7.86e-06	6.57e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—BCHE—malignant glioma	7.8e-06	6.52e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CB—malignant glioma	7.79e-06	6.52e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PPARG—malignant glioma	7.76e-06	6.49e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PPARG—malignant glioma	7.76e-06	6.49e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—BCHE—malignant glioma	7.75e-06	6.48e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.74e-06	6.47e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTGS2—malignant glioma	7.72e-06	6.46e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SLC5A5—malignant glioma	7.7e-06	6.44e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP2C18—malignant glioma	7.7e-06	6.43e-05	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	7.69e-06	6.43e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—SLC5A5—malignant glioma	7.66e-06	6.4e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CG—malignant glioma	7.5e-06	6.27e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTGS1—malignant glioma	7.49e-06	6.26e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.47e-06	6.24e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.46e-06	6.24e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTT1—malignant glioma	7.35e-06	6.14e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GSTP1—malignant glioma	7.33e-06	6.13e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—IL2—malignant glioma	7.31e-06	6.11e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—IDH2—malignant glioma	7.29e-06	6.09e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTT1—malignant glioma	7.29e-06	6.09e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.28e-06	6.09e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.26e-06	6.07e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.24e-06	6.05e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PPARG—malignant glioma	7.24e-06	6.05e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.22e-06	6.03e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GSTP1—malignant glioma	7.18e-06	6e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.18e-06	6e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CAT—malignant glioma	7.13e-06	5.96e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CD—malignant glioma	7.07e-06	5.91e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CD—malignant glioma	7.07e-06	5.91e-05	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	7.05e-06	5.9e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CAT—malignant glioma	6.98e-06	5.84e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—BCHE—malignant glioma	6.96e-06	5.82e-05	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AKT1—malignant glioma	6.92e-06	5.78e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTGS1—malignant glioma	6.89e-06	5.76e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SLC5A5—malignant glioma	6.88e-06	5.75e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.87e-06	5.74e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.85e-06	5.73e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTGS1—malignant glioma	6.83e-06	5.71e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CAV1—malignant glioma	6.8e-06	5.69e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.8e-06	5.69e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GSTP1—malignant glioma	6.77e-06	5.66e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—NCOR1—malignant glioma	6.73e-06	5.63e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTEN—malignant glioma	6.73e-06	5.63e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.61e-06	5.53e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—NCOR1—malignant glioma	6.6e-06	5.51e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CD—malignant glioma	6.59e-06	5.51e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CAT—malignant glioma	6.59e-06	5.51e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.5e-06	5.44e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.44e-06	5.39e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—BCHE—malignant glioma	6.4e-06	5.35e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.38e-06	5.33e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—BCHE—malignant glioma	6.35e-06	5.31e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.32e-06	5.29e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.29e-06	5.26e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.27e-06	5.24e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—IDH1—malignant glioma	6.27e-06	5.24e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.26e-06	5.23e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTT1—malignant glioma	6.23e-06	5.2e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—NCOR1—malignant glioma	6.22e-06	5.2e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—malignant glioma	6.21e-06	5.19e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GSTP1—malignant glioma	6.2e-06	5.19e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CG—malignant glioma	6.2e-06	5.18e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—GSTP1—malignant glioma	6.17e-06	5.16e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CB—malignant glioma	6.16e-06	5.15e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CB—malignant glioma	6.16e-06	5.15e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTGS2—malignant glioma	6.1e-06	5.1e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTGS2—malignant glioma	6.1e-06	5.1e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SPHK1—malignant glioma	6.06e-06	5.07e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CAT—malignant glioma	6.04e-06	5.05e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CAT—malignant glioma	6e-06	5.02e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PPARG—malignant glioma	5.98e-06	5e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.94e-06	4.97e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.93e-06	4.96e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.87e-06	4.91e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTGS1—malignant glioma	5.83e-06	4.88e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.81e-06	4.86e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CB—malignant glioma	5.75e-06	4.8e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—NCOR1—malignant glioma	5.7e-06	4.77e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTGS2—malignant glioma	5.69e-06	4.76e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—NCOR1—malignant glioma	5.67e-06	4.74e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.62e-06	4.7e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GSTP1—malignant glioma	5.54e-06	4.63e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CAV1—malignant glioma	5.49e-06	4.59e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CD—malignant glioma	5.45e-06	4.55e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—BCHE—malignant glioma	5.42e-06	4.53e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CAT—malignant glioma	5.39e-06	4.5e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CAV1—malignant glioma	5.38e-06	4.5e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SLC5A5—malignant glioma	5.36e-06	4.48e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTEN—malignant glioma	5.32e-06	4.45e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTEN—malignant glioma	5.32e-06	4.45e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—KRAS—malignant glioma	5.28e-06	4.41e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.12e-06	4.28e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GSTP1—malignant glioma	5.09e-06	4.26e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—NCOR1—malignant glioma	5.09e-06	4.25e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CAV1—malignant glioma	5.07e-06	4.24e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.07e-06	4.23e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GSTP1—malignant glioma	5.05e-06	4.22e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.02e-06	4.2e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CG—malignant glioma	5e-06	4.18e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTEN—malignant glioma	4.97e-06	4.15e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CAT—malignant glioma	4.96e-06	4.14e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CAT—malignant glioma	4.91e-06	4.11e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CG—malignant glioma	4.9e-06	4.09e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CA—malignant glioma	4.85e-06	4.05e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.84e-06	4.05e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PPARG—malignant glioma	4.83e-06	4.03e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTT1—malignant glioma	4.8e-06	4.02e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CA—malignant glioma	4.75e-06	3.97e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CB—malignant glioma	4.75e-06	3.97e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PPARG—malignant glioma	4.73e-06	3.95e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTGS2—malignant glioma	4.71e-06	3.93e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—malignant glioma	4.69e-06	3.92e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—NCOR1—malignant glioma	4.68e-06	3.91e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CAV1—malignant glioma	4.65e-06	3.89e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—NCOR1—malignant glioma	4.64e-06	3.88e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CAV1—malignant glioma	4.62e-06	3.86e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CG—malignant glioma	4.62e-06	3.86e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTGS1—malignant glioma	4.5e-06	3.76e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PPARG—malignant glioma	4.46e-06	3.73e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.44e-06	3.71e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.42e-06	3.69e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CD—malignant glioma	4.4e-06	3.67e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.38e-06	3.66e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GSTP1—malignant glioma	4.32e-06	3.61e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CD—malignant glioma	4.31e-06	3.6e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CG—malignant glioma	4.23e-06	3.54e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CG—malignant glioma	4.21e-06	3.52e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CAT—malignant glioma	4.2e-06	3.51e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—BCHE—malignant glioma	4.19e-06	3.5e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CAV1—malignant glioma	4.15e-06	3.47e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.13e-06	3.46e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTEN—malignant glioma	4.1e-06	3.43e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PPARG—malignant glioma	4.09e-06	3.42e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PPARG—malignant glioma	4.06e-06	3.4e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CD—malignant glioma	4.06e-06	3.39e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—NCOR1—malignant glioma	3.97e-06	3.31e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.96e-06	3.31e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—AKT1—malignant glioma	3.96e-06	3.31e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AKT1—malignant glioma	3.88e-06	3.24e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CB—malignant glioma	3.83e-06	3.2e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CAV1—malignant glioma	3.82e-06	3.19e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTGS2—malignant glioma	3.8e-06	3.17e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CAV1—malignant glioma	3.78e-06	3.16e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.78e-06	3.16e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CA—malignant glioma	3.76e-06	3.14e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CA—malignant glioma	3.76e-06	3.14e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CB—malignant glioma	3.75e-06	3.14e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CD—malignant glioma	3.72e-06	3.11e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTGS2—malignant glioma	3.72e-06	3.11e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CD—malignant glioma	3.7e-06	3.09e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PPARG—malignant glioma	3.65e-06	3.05e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.61e-06	3.02e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CB—malignant glioma	3.54e-06	2.96e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTGS2—malignant glioma	3.51e-06	2.93e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CA—malignant glioma	3.5e-06	2.93e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.48e-06	2.91e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.45e-06	2.88e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PPARG—malignant glioma	3.35e-06	2.8e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GSTP1—malignant glioma	3.33e-06	2.78e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PPARG—malignant glioma	3.33e-06	2.78e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.32e-06	2.78e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTEN—malignant glioma	3.31e-06	2.77e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CB—malignant glioma	3.24e-06	2.71e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTEN—malignant glioma	3.24e-06	2.71e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CAT—malignant glioma	3.24e-06	2.71e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CAV1—malignant glioma	3.23e-06	2.7e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CB—malignant glioma	3.23e-06	2.7e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTGS2—malignant glioma	3.21e-06	2.69e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTGS2—malignant glioma	3.2e-06	2.67e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.09e-06	2.58e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AKT1—malignant glioma	3.07e-06	2.56e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AKT1—malignant glioma	3.07e-06	2.56e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—NCOR1—malignant glioma	3.06e-06	2.56e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTEN—malignant glioma	3.06e-06	2.56e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.06e-06	2.55e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.03e-06	2.53e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.94e-06	2.46e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.9e-06	2.42e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CA—malignant glioma	2.9e-06	2.42e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTGS2—malignant glioma	2.87e-06	2.4e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AKT1—malignant glioma	2.86e-06	2.39e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PPARG—malignant glioma	2.84e-06	2.38e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTEN—malignant glioma	2.8e-06	2.34e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTEN—malignant glioma	2.79e-06	2.33e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.66e-06	2.23e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.64e-06	2.21e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTGS2—malignant glioma	2.64e-06	2.21e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTGS2—malignant glioma	2.62e-06	2.19e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.59e-06	2.16e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTEN—malignant glioma	2.5e-06	2.09e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CAV1—malignant glioma	2.49e-06	2.09e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AKT1—malignant glioma	2.37e-06	1.98e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.34e-06	1.95e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTEN—malignant glioma	2.3e-06	1.92e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CA—malignant glioma	2.29e-06	1.91e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTEN—malignant glioma	2.28e-06	1.91e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.27e-06	1.9e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.26e-06	1.89e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTGS2—malignant glioma	2.24e-06	1.87e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PPARG—malignant glioma	2.19e-06	1.83e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CA—malignant glioma	2.16e-06	1.8e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CD—malignant glioma	2e-06	1.67e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.98e-06	1.65e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CA—malignant glioma	1.97e-06	1.64e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTEN—malignant glioma	1.95e-06	1.63e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AKT1—malignant glioma	1.91e-06	1.6e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AKT1—malignant glioma	1.87e-06	1.56e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.77e-06	1.48e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AKT1—malignant glioma	1.76e-06	1.47e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.74e-06	1.46e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTGS2—malignant glioma	1.73e-06	1.44e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.62e-06	1.36e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKT1—malignant glioma	1.62e-06	1.35e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.61e-06	1.35e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—AKT1—malignant glioma	1.61e-06	1.34e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTEN—malignant glioma	1.5e-06	1.26e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKT1—malignant glioma	1.44e-06	1.21e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.38e-06	1.15e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKT1—malignant glioma	1.33e-06	1.11e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKT1—malignant glioma	1.31e-06	1.1e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKT1—malignant glioma	1.12e-06	9.39e-06	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.06e-06	8.87e-06	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKT1—malignant glioma	8.67e-07	7.25e-06	CbGpPWpGaD
